Lanxess AG
XMUN:LXS
Lanxess AG
XMUN:LXS
Price:
18.25
EUR
3.46%
Market Cap:
€3.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lanxess AG
XMUN:LXS
|
DE |
|
G
|
Givaudan SA
XMUN:GIN
|
CH |
|
Cosmo Pharmaceuticals NV
OTC:CMOPF
|
IE |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
C
|
China Overseas Land & Investment Ltd
XMUN:CPP
|
HK |
|
Pernod Ricard SA
F:PER0
|
FR |
|
B
|
Best Buy Co Inc
BMV:BBY
|
US |
|
R
|
Republic Services Inc
DUS:RPU
|
US |
|
A
|
Abbott Laboratories
LSE:0Q15
|
US |
|
A
|
American Tower Corp
F:A0T
|
US |
|
M
|
Microsoft Corp
XMUN:MSF
|
US |
Wall St Price Targets
LXS Price Targets Summary
Lanxess AG
Lanxess AG
Wall Street analysts forecast LXS stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for LXS is 17.39 EUR with a low forecast of 9.83 EUR and a high forecast of 30.66 EUR.
Lowest Forecast
Price Target
9.83
EUR
46% Downside
Average Forecast
Price Target
17.39
EUR
5% Downside
Highest Forecast
Price Target
30.66
EUR
68% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LXS's stock price target?
Price Target
17.39
EUR
17.39
EUR
According to Wall Street analysts, the average 1-year price target for LXS is 17.39 EUR with a low forecast of 9.83 EUR and a high forecast of 30.66 EUR.
What is the Revenue forecast for Lanxess AG?
Projected CAGR
7%
7%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 6 years is 7%.
